Blennow K - Search Results

1

Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years.

Stomrud E, Hansson O, Minthon L, Blennow K, Rosén I, Londos E. Stomrud E, et al. Among authors: blennow k. Neurobiol Aging. 2010 Feb;31(2):215-23. doi: 10.1016/j.neurobiolaging.2008.03.025. Neurobiol Aging. 2010. PMID: 18462837

2

The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease.

Minthon L, Hesse C, Sjögren M, Englund E, Gustafson L, Blennow K. Minthon L, et al. Among authors: blennow k. Neurosci Lett. 1997 Apr 18;226(1):65-7. doi: 10.1016/s0304-3940(97)00230-9. Neurosci Lett. 1997. PMID: 9153643

3

Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease.

Sjögren M, Minthon L, Passant U, Blennow K, Wallin A. Sjögren M, et al. Among authors: blennow k. Neurobiol Aging. 1998 Sep-Oct;19(5):379-84. doi: 10.1016/s0197-4580(98)00086-4. Neurobiol Aging. 1998. PMID: 9880039

4

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

Andreasen N, Hesse C, Davidsson P, Minthon L, Wallin A, Winblad B, Vanderstichele H, Vanmechelen E, Blennow K. Andreasen N, et al. Among authors: blennow k. Arch Neurol. 1999 Jun;56(6):673-80. doi: 10.1001/archneur.56.6.673. Arch Neurol. 1999. PMID: 10369305

5

Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment.

Andreasen N, Minthon L, Vanmechelen E, Vanderstichele H, Davidsson P, Winblad B, Blennow K. Andreasen N, et al. Among authors: blennow k. Neurosci Lett. 1999 Sep 24;273(1):5-8. doi: 10.1016/s0304-3940(99)00617-5. Neurosci Lett. 1999. PMID: 10505638 Clinical Trial.

6

Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample.

Andreasen N, Minthon L, Clarberg A, Davidsson P, Gottfries J, Vanmechelen E, Vanderstichele H, Winblad B, Blennow K. Andreasen N, et al. Among authors: blennow k. Neurology. 1999 Oct 22;53(7):1488-94. doi: 10.1212/wnl.53.7.1488. Neurology. 1999. PMID: 10534256

7

[New discoveries on Alzheimer disease: new biochemical markers can hopefully improve diagnosis].

Blennow K, Minthon L, Wallin A. Blennow K, et al. Lakartidningen. 2000 Jan 12;97(1-2):6-10. Lakartidningen. 2000. PMID: 10668317 Review. Swedish. No abstract available.

8

Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD.

Sjögren M, Rosengren L, Minthon L, Davidsson P, Blennow K, Wallin A. Sjögren M, et al. Among authors: blennow k. Neurology. 2000 May 23;54(10):1960-4. doi: 10.1212/wnl.54.10.1960. Neurology. 2000. PMID: 10822437

9

Measurement of apolipoprotein E (apoE) in cerebrospinal fluid.

Hesse C, Larsson H, Fredman P, Minthon L, Andreasen N, Davidsson P, Blennow K. Hesse C, et al. Among authors: blennow k. Neurochem Res. 2000 Apr;25(4):511-7. doi: 10.1023/a:1007516210548. Neurochem Res. 2000. PMID: 10823584

10

TNF gene polymorphism and its relation to intracerebral production of TNFalpha and TNFbeta in AD.

Tarkowski E, Liljeroth AM, Nilsson A, Ricksten A, Davidsson P, Minthon L, Blennow K. Tarkowski E, et al. Among authors: blennow k. Neurology. 2000 Jun 13;54(11):2077-81. doi: 10.1212/wnl.54.11.2077. Neurology. 2000. PMID: 10851366

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,199 results

Search Page

Filters